53 related articles for article (PubMed ID: 940364)
1. Clinical follow-up and the cell-mediated cytotoxicity against HeLa cells in patients with invasive or preinvasive cervical cancer.
Saksela E; Meyer B
Med Biol; 1976 Jun; 54(3):217-22. PubMed ID: 940364
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
Dini MM; Jafari K; Faiferman I
Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated cytotoxicity against HeLa cells in patients with invasive or preinvasive cervical cancer.
Saksela E; Meyer B
J Natl Cancer Inst; 1973 Oct; 51(4):1095-102. PubMed ID: 4745849
[No Abstract] [Full Text] [Related]
4. Long-term treatment results of invasive cervical cancer patients undergoing inadvertent hysterectomy followed by salvage radiotherapy.
Hsu WL; Shueng PW; Jen YM; Wu CJ; Hwang JM; Chang LP; Chen CM; Lin LC; Teh BS
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):521-7. PubMed ID: 15145172
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
6. [Suppression of cellular immunity in patients with carcinoma in situ and microinvasive cancer of the cervix uteri].
Marinova-Mutafchieva LP; Chakalova GB; Goranov IT
Vopr Onkol; 1991; 37(4):454-7. PubMed ID: 1832253
[TBL] [Abstract][Full Text] [Related]
7. Conization for cervical dysplasia and carcinoma in situ: long term follow-up of 1013 women.
Larsson G
Ann Chir Gynaecol; 1981; 70(2):79-85. PubMed ID: 7316444
[TBL] [Abstract][Full Text] [Related]
8. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
Bosković V; Glisić A; Petković S
Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
[TBL] [Abstract][Full Text] [Related]
9. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay.
Holloway RW; To A; Moradi M; Boots L; Watson N; Shingleton HM
Obstet Gynecol; 1989 Dec; 74(6):944-9. PubMed ID: 2586961
[TBL] [Abstract][Full Text] [Related]
10. The invasive potential of carcinoma in situ of the cervix.
McIndoe WA; McLean MR; Jones RW; Mullins PR
Obstet Gynecol; 1984 Oct; 64(4):451-8. PubMed ID: 6483293
[TBL] [Abstract][Full Text] [Related]
11. [Studies on host immunity in cervical cancer--alterations in nonspecific and specific immunity of tumor growth (author's transl)].
Yamada Y
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Nov; 32(11):1820-8. PubMed ID: 7240835
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of the EA-rosette test in the early detection of cervical cancer.
Wagner D; Noltenius HW
Acta Cytol; 1983; 27(4):403-7. PubMed ID: 6576540
[TBL] [Abstract][Full Text] [Related]
13. Cure rates after laser conization for early cervical neoplasia.
Grundsell H; Alm P; Larsson G
Ann Chir Gynaecol; 1983; 72(4):218-22. PubMed ID: 6638907
[TBL] [Abstract][Full Text] [Related]
14. Papillomavirus infection of the cervix. II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins.
Kurman RJ; Jenson AB; Lancaster WD
Am J Surg Pathol; 1983 Jan; 7(1):39-52. PubMed ID: 6299124
[TBL] [Abstract][Full Text] [Related]
15. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
Chen Y; Xu H; Li Y; Wang D; Li J; Yuan J; Liang Z
Ann Surg Oncol; 2008 Oct; 15(10):2847-55. PubMed ID: 18649105
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.
Steller MA; Gurski KJ; Murakami M; Daniel RW; Shah KV; Celis E; Sette A; Trimble EL; Park RC; Marincola FM
Clin Cancer Res; 1998 Sep; 4(9):2103-9. PubMed ID: 9748126
[TBL] [Abstract][Full Text] [Related]
17. Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix.
Morris M; Mitchell MF; Silva EG; Copeland LJ; Gershenson DM
Gynecol Oncol; 1993 Nov; 51(2):193-6. PubMed ID: 8276293
[TBL] [Abstract][Full Text] [Related]
18. [Blast transformation of the peripheral lymphocytes in cervical cancer during the radiotherapy process].
Shiriĭ AV
Vopr Onkol; 1975; 21(3):35-40. PubMed ID: 1130018
[TBL] [Abstract][Full Text] [Related]
19. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
Göcze P; Vahrson H
Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma in situ of the cervix: management and outcome.
Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
